[1]王 敏,裴巧丽,朱丽红,等.缺铁性贫血孕妇血清可溶性转铁蛋白受体、膜铁转运蛋白1、对氧磷酶1表达水平及检测意义[J].陕西医学杂志,2024,(8):1106-1109.[doi:DOI:10.3969/j.issn.1000-7377.2024.08.022]
　WANG Min,PEI Qiaoli,ZHU Lihong,et al.Expression levels and significance of soluble transferrin receptor,ferroportin 1,paraoxonase 1 in pregnant women with iron deficiency anemia[J].,2024,(8):1106-1109.[doi:DOI:10.3969/j.issn.1000-7377.2024.08.022]
点击复制

缺铁性贫血孕妇血清可溶性转铁蛋白受体、膜铁转运蛋白1、对氧磷酶1表达水平及检测意义
分享到：

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
期数:
2024年8期
页码:
1106-1109
栏目:
临床检验
出版日期:
2024-08-05

文章信息/Info

Title:
Expression levels and significance of soluble transferrin receptor,ferroportin 1,paraoxonase 1 in pregnant women with iron deficiency anemia
作者:
王 敏; 裴巧丽; 朱丽红; 袁宁霞; 张小菜; 徐 珊; 陈 蓓
(陕西中医药大学第二附属医院产科,陕西 咸阳 712000)
Author(s):
WANG Min; PEI Qiaoli; ZHU Lihong; YUAN Ningxia; ZHANG Xiaocai; XU Shan; CHEN Bei
(Department of Obstetrics,the Second Affiliated Hospital of Shaanxi University of Chinese Medicine,Xianyang 712000,China)
关键词:
缺铁性贫血;  可溶性转铁蛋白受体;  膜铁转运蛋白1;  对氧磷酶1;  诊断价值;  孕妇
Keywords:
Iron deficiency anemia;  Soluble transferrin receptor;  Ferroportin 1;  Paraoxonase 1;  Diagnostic value;  Pregnant women
分类号:
R 556.3
DOI:
DOI:10.3969/j.issn.1000-7377.2024.08.022
文献标志码:
A
摘要:
目的:探讨可溶性转铁蛋白受体(sTfR)、膜铁转运蛋白1(FPN1)、对氧磷酶1(PON1)在缺铁性贫血(IDA)孕妇中的表达及意义。方法:选取IDA孕妇182例为IDA组,根据IDA严重程度将IDA组分为轻度组(80例)、中度组(61例)和重度组(41例),另选取同期健康孕妇73例为健康对照组。比较各组孕妇血清sTfR、FPN1、PON1水平。比较IDA组和健康对照组贫血相关指标。分析血清sTfR、FPN1、PON1水平与血红蛋白(Hb)、平均红细胞体积(MCV)、血清铁蛋白(SF)水平的相关性。绘制受试者工作特征(ROC)曲线分析血清sTfR、FPN1、PON1对孕妇IDA的诊断价值。记录所有孕妇不良结局发生情况,根据最终母婴结局将所有研究对象分为母婴结局正常组(179例)和母婴结局不良组(76例)。比较不同母婴结局孕妇血清sTfR、FPN1、PON1水平。结果:与健康对照组比较,IDA组sTfR、FPN1水平升高,PON1水平降低(均P<0.05)。IDA组Hb、MCV、SF水平低于健康对照组(均P<0.05)。血清sTfR、FPN1与Hb、MCV、SF呈负相关,PON1与Hb、MCV、SF呈正相关(均P<0.05)。血清sTfR、FPN1、PON1对孕妇IDA均有一定诊断效能,且联合检测诊断价值更高(均P<0.05)。重度组血清sTfR、FPN1水平高于轻度和中度组,PON1水平低于轻度和中度组(均P<0.05)。与健康对照组比较,IDA组母婴不良结局总发生率更高(P<0.05)。与母婴结局正常组比较,母婴结局不良组血清sTfR、FPN1水平升高,PON1水平降低(均P<0.05)。结论:血清sTfR、FPN1、PON1在IDA孕妇中均呈异常表达,三者联合检测对IDA诊断效能较高,且与IDA严重程度和母婴结局有关。
Abstract:
Objective:To investigate the expression and significance of soluble transferrin receptor(sTfR),ferroportin 1(FPN1)and paraoxonase 1(PON1)in pregnant women with iron deficiency anemia(IDA).Methods:A total of 182 pregnant women with IDA were selected as IDA group,and the IDA group was divided into mild group(80 cases),moderate group(61 cases)and severe group(41 cases)according to the severity of IDA,and 73 healthy pregnant women were selected as healthy control group.The serum levels of sTfR,FPN1 and PON1 were compared among all groups.The anemia-related indexes of IDA group and healthy control group were compared.The correlation between serum sTfR,FPN1,PON1 levels and hemoglobin(Hb),mean corpuscular volume(MCV)and serum ferritin(SF)levels was analyzed.Receiver operating characteristic(ROC)curve was drawn to analyze the diagnostic value of serum sTfR,FPN1 and PON1 for IDA in pregnant women.Adverse outcomes of all pregnant women were recorded,and all subjects were divided into normal maternal and infant outcome group(179 cases)and adverse maternal and infant outcome group(76 cases)according to the final maternal and infant outcome.The serum sTfR,FPN1 and PON1 levels of pregnant women with different outcomes were compared.Results:Compared with the healthy control group,the levels of sTfR and FPN1 in IDA group were increased,and the levels of PON1 were decreased(all P<0.05).The levels of Hb,MCV and SF in IDA group were lower than those in healthy control group(all P<0.05).Serum sTfR and FPN1 were negatively correlated with Hb,MCV and SF,while PON1 was positively correlated with Hb,MCV and SF(all P<0.05).Serum sTfR,FPN1 and PON1 had certain diagnostic efficacy for IDA in pregnant women,and the combined detection had higher diagnostic value(all P<0.05).Serum sTfR and FPN1 levels in severe group were higher than those in mild and moderate groups,and PON1 levels were lower than those in mild and moderate groups(all P<0.05).Compared with the healthy control group,the overall incidence of adverse outcomes was higher in IDA group(P<0.05).Compared with the normal maternal and infant outcome group,the serum sTfR and FPN1 levels were increased and PON1 levels were decreased in the poor maternal and infant outcome group(all P<0.05).Conclusion:Serum sTfR,FPN1 and PON1 are abnormally expressed in pregnant women with IDA,and the combined detection of the three has high diagnostic efficacy in the diagnosis of IDA,and they are related to the severity of IDA and maternal and infant outcomes.

参考文献/References:

[1] 黄飞燚,夏苏桦.妊娠期妇女缺铁性贫血的危险因素[J].广西医学,2018,40(7):771-774.
[2] 孙利,吴宁莉,王林,等.蛋白琥珀酸铁口服溶液与多糖铁复合物胶囊治疗妊娠期缺铁性贫血疗效及对妊娠结局影响对比研究[J].陕西医学杂志,2022,51(2):226-229.
[3] RAHMATI S,DELPISHE A,AZAMI M,et al.Maternal anemia during pregnancy and infant low birth weight:A systematic review and meta-analysis[J].Int J Reprod Biomedicine,2017,15(3):125-134.
[4] 范春丽,罗家有,龚雯洁,等.妊娠期并发贫血影响因素的巢式病例对照研究[J].中华流行病学杂志,2017,38(9):1269-1273.
[5] GUO W,WANG H,LIU Q,et al.Analysis of the correlation of gestational diabetes mellitus and peripheral ferritin with iron levels in early pregnancy[J].Minerva Endocrinol,2019,44(1):91-96.
[6] 夏红灯,胡天钰,史德宝,等.铁代谢指标对缺铁性贫血的诊断性能评估[J].安徽医科大学学报,2018,53(9):1465-1468.
[7] 吴进,李慧,肖凯,等.右旋糖酐铁联合EPO治疗妊娠期缺铁性贫血疗效及其对RET、Hepcidin-25水平的影响[J].疑难病杂志,2021,20(5):492-496.
[8] 张楷齐,吴晶魁,姜娜,等.铁死亡抑制剂通过保护膜铁转运蛋白减轻脓毒症相关急性肾损伤[J].中国临床医学,2023,30(2):229-237.
[9] 董淑晓,刘志虎,刘慧丽,等.PON1、HtrA4与拉贝洛尔治疗子痫前期合并代谢综合征效果的相关性研究[J].河北医科大学学报,2020,41(9):1053-1057.
[10] 晋艳婷,赵兴丹,翁艾罕,等.Hepcidin-25、HbA2、PON1表达水平在预测妊娠期缺铁性贫血中的价值[J].国际检验医学杂志,2022,43(21):2573-2577.
[11] 齐薇薇,邵宗鸿.《妊娠期铁缺乏和缺铁性贫血诊治指南》解读[J].中国实用内科杂志,2015,35(2):136-138.
[12] 齐亮,邱辉,付玉.血清铁调素-25水平对妊娠期缺铁性贫血诊治的意义及与围产结局的关系[J].中国临床研究,2019,32(11):1471-1475.
[13] 邹国辉,戴祺,郑冰冰,等.调中化湿汤联合益生菌治疗HP相关性慢性胃炎合并缺铁性贫血临床研究[J].陕西中医,2021,42(7):914-917.
[14] 陈露.血清铁参数和血小板参数与老年人群缺铁性贫血及严重程度关系及其诊断价值研究[J].陕西医学杂志,2023,52(9):1237-1240.
[15] 王青波,林宏,张国军,等.sTfR、EPO的检测对孕妇缺铁性贫血诊断价值分析[J].标记免疫分析与临床,2019,26(1):37-39.
[16] 徐蕾,邓晓杨.早期检测及干预铁缺乏对妊娠期缺铁性贫血影响的研究[J].标记免疫分析与临床,2017,24(1):45-47.
[17] 陈翠娜,黄沛嫔,巫华玉.妊娠期血清铁、铁蛋白、可溶性转铁蛋白受体水平与贫血的关系[J].中国性科学,2019,28(11):49-52.
[18] 陈梨春,尤昕,陈丽婷.妊娠期缺铁性贫血患者血清sTfR、GDF-15水平与产后早期泌乳量的相关性[J].广西医学,2022,44(23):2749-2753.
[19] 单秀玲,董其虎,孙璐,等.孕早期铁缺乏与妊娠和出生结局关系[J].中国计划生育学杂志,2019,27(12):1704-1706.
[20] 李芬,安文茜,贺杰,等.血清同型半胱氨酸、维生素B12和可溶性转铁蛋白受体联合检测对妊娠期贫血早期诊断的价值分析[J].安徽医药,2022,26(7):1336-1340.
[21] 徐帆,胡乃中,梅俏.可溶性转铁蛋白受体及其复合参数在诊断炎症性肠病合并缺铁性贫血中的临床价值[J].安徽医科大学学报,2018,53(7):1110-1114.
[22] MCDONALD E A,GUNDOGAN F,OLVEDA R M,et al.Iron transport across the human placenta is regulated by hepcidin[J].Pediatr Res,2020,92(2):396-402.
[23] 周士华,杜景云,李亚梅,等.可溶性转铁蛋白受体、膜铁转运蛋白1、铁幼素对妊娠妇女缺铁性贫血的诊断价值[J].标记免疫分析与临床,2019,26(3):464-467.
[24] 张琳,宋玮钕,黄桉风.妊娠期缺铁性贫血患者血Hb、SF、PON1水平与围生结局的关系[J].浙江医学,2019,41(12):1295-1297.
[25] 曹羽,俞秋艳,苗春菊.妊娠期缺铁性贫血相关指标及对氧磷酶-1水平与围生结局的关系[J].临床血液学杂志,2022,35(2):117-120.

相似文献/References:

[1]李芝帆,王君兰,张 健,等.陕西省商州区2215例0～6岁儿童缺铁性贫血患病现状调查及影响因素分析[J].陕西医学杂志,2021,50(8):1027.[doi:DOI:10.3969/j.issn.1000-7377.2021.08.031]
　LI Zhifan,WANG Junlan,ZHANG Jian,et al.Investigation and analysis of IDA in 2215 children aged 0～6 years in Shangzhou District,Shaanxi Province[J].,2021,50(8):1027.[doi:DOI:10.3969/j.issn.1000-7377.2021.08.031]
[2]孙 利,吴宁莉,王 林,等.蛋白琥珀酸铁口服溶液与多糖铁复合物胶囊治疗妊娠期缺铁性贫血疗效及对妊娠结局影响对比研究[J].陕西医学杂志,2022,51(2):226.[doi:DOI:10.3969/j.issn.1000-7377.2022.02.023]
[3]陈 露.血清铁参数和血小板参数与老年人群缺铁性贫血及严重程度关系及其诊断价值研究[J].陕西医学杂志,2023,52(9):1237.[doi:DOI:10.3969/j.issn.1000-7377.2023.09.029]
　CHEN Lu.Relationship of serum iron parameters,platelet parameters with iron deficiency anemia and severity in elderly and their diagnostic value[J].,2023,52(8):1237.[doi:DOI:10.3969/j.issn.1000-7377.2023.09.029]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金资助项目(81774133)
更新日期/Last Update: 2024-08-08